ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,867.08
      -0.09%
      US Tech 100
      20,485.20
      -0.84%
      Dow Jones
      42,342.24
      0.04%
      Brent Oil
      72.295
      -0.12%
      Bitcoin
      96,094.72
      -1.40%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Wave Life Sciences Ltd (WVE) Quote

      Wave Life Sciences Ltd

      Wave Life Sciences Ltd (WVE)

      NASDAQ
      13.19
      0.10
      (0.76%)
      Closed December 19 4:00PM
      Delayed by 15 minutes
      13.27
      0.08
      (0.61%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      13.27
      Bid
      13.27
      Ask
      14.62
      Volume
      902,869
      12.8902 Day's Range 13.55
      3.50 52 Week Range 16.735
      Market Cap
      2.024B
      Previous Close
      13.09
      Open
      13.08
      Last Trade
      252
      @
      13.27
      (formt)
      Last Trade Time
      Financial Volume
      $ 11,842,987
      VWAP
      13.1171
      Average Volume (3m)
      1,636,922
      Shares Outstanding
      152,519,770
      Dividend Yield
      -
      PE Ratio
      -34.95
      Earnings Per Share (EPS)
      -0.38
      Revenue
      115.18M
      Net Profit
      -57.51M

      About Wave Life Sciences Ltd

      WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic def... WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.wavelifesciences.com
      Headquarters
      Singapore, Sgp
      Founded
      -
      Wave Life Sciences Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker WVE. The last closing price for Wave Life Sciences was $13.09. Over the last year, Wave Life Sciences shares have traded in a share price range of $ 3.50 to $ 16.735.

      Wave Life Sciences currently has 152,519,770 shares outstanding. The market capitalization of Wave Life Sciences is $2 billion. Wave Life Sciences has a price to earnings ratio (PE ratio) of -34.95.

      Ask ADVFN Intelligence (AI)

      WVE Latest News

      More News

      Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

      CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

      December 16 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      November 27 2024
      Edgar (US Regulatory)

      Wave Life Sciences to Present at Upcoming Investor Conferences

      CAMBRIDGE, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

      November 26 2024
      GlobeNewswire Inc.

      Form 144 - Report of proposed sale of securities

      November 25 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 20 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 15 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      November 15 2024
      Edgar (US Regulatory)

      Wave Life Sciences to Present at Jefferies London Healthcare Conference

      CAMBRIDGE, Mass., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

      November 15 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      November 13 2024
      Edgar (US Regulatory)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 12 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.77-11.768617021315.0415.4912.84116583113.75788622CS
      4-0.97-6.8117977528114.2416.384112.8497794214.48819162CS
      124.9559.49519230778.3216.7357.85163692213.14141992CS
      267.61134.452296825.6616.7354.25141247410.01069218CS
      528.47176.4583333334.816.7353.510937838.42851083CS
      15610.05312.1118012423.2216.7351.166685216.3914048CS
      260-2.18-14.110032362515.4519.981.166860877.2717831CS

      WVE - Frequently Asked Questions (FAQ)

      What is the current Wave Life Sciences share price?
      The current share price of Wave Life Sciences is $ 13.27
      How many Wave Life Sciences shares are in issue?
      Wave Life Sciences has 152,519,770 shares in issue
      What is the market cap of Wave Life Sciences?
      The market capitalisation of Wave Life Sciences is USD 2B
      What is the 1 year trading range for Wave Life Sciences share price?
      Wave Life Sciences has traded in the range of $ 3.50 to $ 16.735 during the past year
      What is the PE ratio of Wave Life Sciences?
      The price to earnings ratio of Wave Life Sciences is -34.95
      What is the cash to sales ratio of Wave Life Sciences?
      The cash to sales ratio of Wave Life Sciences is 17.45
      What is the reporting currency for Wave Life Sciences?
      Wave Life Sciences reports financial results in USD
      What is the latest annual turnover for Wave Life Sciences?
      The latest annual turnover of Wave Life Sciences is USD 115.18M
      What is the latest annual profit for Wave Life Sciences?
      The latest annual profit of Wave Life Sciences is USD -57.51M
      What is the registered address of Wave Life Sciences?
      The registered address for Wave Life Sciences is 8 CROSS STREET #10-00�����, PWC BUILDINGE, SINGAPORE, 018936
      What is the Wave Life Sciences website address?
      The website address for Wave Life Sciences is www.wavelifesciences.com
      Which industry sector does Wave Life Sciences operate in?
      Wave Life Sciences operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      PRFXPainReform Ltd
      $ 11.08
      (410.60%)
      		95.26M
      NVNINVNI Group Ltd
      $ 2.66
      (315.63%)
      		20.62M
      BPTHBio Path Holdings Inc
      $ 1.50
      (124.22%)
      		112.72M
      ZCARZoomcar Holdings Inc
      $ 2.5999
      (96.96%)
      		18.03M
      APCXAppTech Payments Corporation
      $ 0.6203
      (62.81%)
      		195.21M
      LITMSnow Lake Resources Ltd
      $ 0.3025
      (-63.09%)
      		72.24M
      BSFCBlue Star Foods Corporation
      $ 0.1478
      (-48.14%)
      		7.45M
      QUBTQuantum Computing Inc
      $ 15.1396
      (-41.05%)
      		122.47M
      QMCOQuantum Corporation
      $ 36.02
      (-39.99%)
      		7.07M
      AEMDAethlon Medical Inc
      $ 0.4232
      (-35.94%)
      		9.52M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.561
      (53.78%)
      		723.78M
      NVDANVIDIA Corporation
      $ 130.68
      (1.37%)
      		204.23M
      APCXAppTech Payments Corporation
      $ 0.6203
      (62.81%)
      		195.21M
      RGTIRigetti Computing Inc
      $ 7.465
      (-30.17%)
      		173.78M
      SOUNSoundHound AI Inc
      $ 18.855
      (-9.55%)
      		136.68M

      WVE Discussion

      View Posts
      TechandBio TechandBio 1 week ago
      Will wait for buyout on my $6.80 average here.

      $WVE
      👍️0
      TechandBio TechandBio 2 months ago
      RNAI stocks are going to be the biggest driver in biotech in the through 2030 WAVE and PRQR
      These could be the next ALNY
      450 drugs in the pipeline worldwide for RNAI drugs.

      $WVE
      👍️0
      boston127 boston127 2 months ago
      Gotta love their business.

      If their RNA model works, it could have fantastic results for humanity.
      👍️0
      PonkenPlonken PonkenPlonken 2 months ago
      Finally,,,,,,,, "they" will water them all and things will get going. RNA in genetic diseases....
      👍️0
      PonkenPlonken PonkenPlonken 2 months ago
      beautiful....
      👍️0
      Awl416 Awl416 2 months ago
      Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
      👍️0
      TechandBio TechandBio 3 months ago
      WVE Can't wait for the Phase 1 Obesity indication to commence later this year or early 2025 thats the icing on the cake.

      $WVE
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      can you say breakout?
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      why claim this afterwards? Pointless
      👍️0
      TechandBio TechandBio 3 months ago
      Poetry in Motion!

      $WVE
      👍️0
      TechandBio TechandBio 3 months ago
      Solid looking for more!

      Glad I doubled up last week!

      $WVE
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      wowser there it is

      Dystrophin results from a pre-specified analysis of ambulatory boys showed:
      Mean absolute muscle content-adjusted dystrophin expression was 9.0% (range: 4.6-13.9%) and mean absolute unadjusted dystrophin expression was 5.5% of normal (range: 3.3-8.3%), as measured by Western Blot.
      [...]
      89% of ambulatory participants achieved muscle content-adjusted dystrophin levels of at least 5%.
      👍️ 1
      Monksdream Monksdream 3 months ago
      WVE under $7
      👍️0
      Monksdream Monksdream 6 months ago
      WVE under $10
      👍️0
      PonkenPlonken PonkenPlonken 6 months ago
      one of the singaporean companies that does not look like a scam but rather like singaporean excellence.
      👍️0
      Monksdream Monksdream 8 months ago
      WVE under $10
      👍️0
      Monksdream Monksdream 9 months ago
      WVE new 52 week high
      👍️0
      TrendTrade2016 TrendTrade2016 9 months ago
      WVE...BEAUTIFUL WEEKLY
      👍️0
      TrendTrade2016 TrendTrade2016 9 months ago
      WVE...BIO MONSTER SETTING UP
      👍️0
      PRIVATE SHAREHOLDER PRIVATE SHAREHOLDER 2 years ago
      Big clinical news coming shortly
      👍️0
      PRIVATE SHAREHOLDER PRIVATE SHAREHOLDER 2 years ago
      Company reporting big news next week. Stay tuned!
      👍️0
      MiamiGent MiamiGent 2 years ago
      WVE stretched out this morning!

      WAVE LIFE SCIENCES LTD
      $5.24 +$0.20 (+3.97%)

      WVE is a real stock!

      https://stockcharts.com/h-sc/ui?s=WVE
      👍️0

      Your Recent History

      NASDAQ
      WVE
      Wave Life Sciences
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads